LONDON, May 31, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation, today announced that Co-founder and Chief Innovation Officer Dr. Ekaterina Malievskaia will step down from her executive role effective June 16, 2023. She will remain a member of the COMPASS Pathways Board of…


Previous articleSilo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
Next articleBREAKING: State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine